Robert H. Springer

603 total citations
29 papers, 465 citations indexed

About

Robert H. Springer is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Robert H. Springer has authored 29 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 16 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Robert H. Springer's work include Synthesis and Characterization of Heterocyclic Compounds (9 papers), Synthesis and Reactions of Organic Compounds (8 papers) and Synthesis and biological activity (7 papers). Robert H. Springer is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (9 papers), Synthesis and Reactions of Organic Compounds (8 papers) and Synthesis and biological activity (7 papers). Robert H. Springer collaborates with scholars based in United States. Robert H. Springer's co-authors include Roland K. Robins, Jon P. Miller, Darrell E. O'Brien, Thomas Novinson, C. C. Cheng, K. SENGA, Muthiah Manoharan, Ganapathi R. Revankar, David Streeter and Bruce S. Ross and has published in prestigious journals such as Biochemistry, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Robert H. Springer

28 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert H. Springer United States 11 282 217 35 30 21 29 465
Darrell E. O'Brien United States 13 412 1.5× 148 0.7× 44 1.3× 27 0.9× 19 0.9× 37 537
D. J. Brown Australia 11 265 0.9× 148 0.7× 10 0.3× 12 0.4× 10 0.5× 35 378
Charles E. Carter United States 5 38 0.1× 165 0.8× 9 0.3× 14 0.5× 12 0.6× 9 244
Richard E. Holmes United States 9 199 0.7× 259 1.2× 3 0.1× 23 0.8× 73 3.5× 16 445
Saroop S. Matharu 9 296 1.0× 130 0.6× 15 0.5× 15 0.7× 11 382
Arthur A. Santilli United States 11 359 1.3× 140 0.6× 1 0.0× 20 0.7× 13 0.6× 48 440
Teng Jiam Liak Canada 7 365 1.3× 221 1.0× 50 1.7× 17 0.8× 7 478
Carlos J. A. Ribeiro Portugal 13 230 0.8× 150 0.7× 5 0.1× 65 2.2× 13 0.6× 15 350
Peter K. Bridson United States 11 142 0.5× 167 0.8× 1 0.0× 25 0.8× 26 1.2× 22 298
Philip M. Carabateas United States 14 263 0.9× 146 0.7× 43 1.4× 45 2.1× 35 441

Countries citing papers authored by Robert H. Springer

Since Specialization
Citations

This map shows the geographic impact of Robert H. Springer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Springer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Springer more than expected).

Fields of papers citing papers by Robert H. Springer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Springer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Springer. The network helps show where Robert H. Springer may publish in the future.

Co-authorship network of co-authors of Robert H. Springer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Springer. A scholar is included among the top collaborators of Robert H. Springer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Springer. Robert H. Springer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ross, Bruce S., Robert H. Springer, & Vasulinga T. Ravikumar. (2008). An Efficient and Scalable Synthesis of 2,6-Diaminopurine Riboside. Nucleosides Nucleotides & Nucleic Acids. 27(1). 67–69. 3 indexed citations
3.
Ross, Bruce S., et al.. (1999). A New, Efficient Exocyclic Amine Protection Scheme for 2-Aminoadenosine and Derivatives for Incorporation into Oligonucleotides. Nucleosides and Nucleotides. 18(6-7). 1203–1204. 1 indexed citations
4.
Ross, Bruce S., Robert H. Springer, Kelly G. Sprankle, & Guillermo Vasquez. (1997). An Efficient and Scalable Synthesis of Arabinosylguanine and 2′-Deoxy-2′-Fluoro-guanosine. Nucleosides and Nucleotides. 16(7-9). 1645–1647. 3 indexed citations
5.
Manoharan, Muthiah, et al.. (1993). Introduction of a lipophilic thioether tether in the minor groove of nucleic acids for antisense applications. Bioorganic & Medicinal Chemistry Letters. 3(12). 2765–2770. 24 indexed citations
6.
Manoharan, Muthiah, D. P. C. MCGEE, Charles J. Guinosso, et al.. (1992). Chemical Modifications to Improve Uptake and Bioavailability of Antisense Oligonucleotides. Annals of the New York Academy of Sciences. 660(1). 306–309. 12 indexed citations
7.
Robins, Roland K., Ganapathi R. Revankar, Darrell E. O'Brien, et al.. (1985). Purine analog inhibitors of xanthine oxidase ‐ structure activity relationships and proposed binding of the molybdenum cofactor. Journal of Heterocyclic Chemistry. 22(3). 601–634. 91 indexed citations
8.
Miller, Jon P., Caroline C. Sigman, H.L. Johnson, et al.. (1984). Inhibition of cyclic AMP phosphodiesterases by cyclic nucleotide analogs and nitrogen heterocycles.. PubMed. 16. 277–90. 3 indexed citations
9.
Novinson, Thomas, et al.. (1982). 2-(Alkylthio)-1,2,4-triazolo[1,5-a]pyrimidines as adenosine 3',5'-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agents. Journal of Medicinal Chemistry. 25(4). 420–426. 55 indexed citations
10.
O'Brien, Darrell E., Robert H. Springer, & C. C. Cheng. (1966). A new mannich reaction of pyrimidines. Journal of Heterocyclic Chemistry. 3(1). 115–116. 3 indexed citations
11.
Springer, Robert H., et al.. (1965). Studies on 2-(α-Hydroxybenzyl)benzimidazole (HBB) Analogs. I. Synthesis of 8-(α-Hydroxybenzyl)purines, the Diaza Analogs of HBB1a,b. Journal of Medicinal Chemistry. 8(6). 797–802. 1 indexed citations
12.
Springer, Robert H., et al.. (1965). Amino Acids. I. DL‐β‐(diazaphenyl)alanines. Journal of Heterocyclic Chemistry. 2(1). 1–6. 9 indexed citations
13.
Honigberg, I.L., et al.. (1963). Synthetic Approaches to Quinoxaline Antibiotics. Synthesis of Bisquinoxaloyl Derivatives1a. The Journal of Organic Chemistry. 28(4). 1119–1122. 9 indexed citations
14.
Springer, Robert H., et al.. (1963). Synthesis of Some Hydrazono Derivatives of p-[N,N-Bis(β-chloroethyl)amino]benzaldehyde. Journal of Pharmaceutical Sciences. 52(1). 81–83. 1 indexed citations
15.
Springer, Robert H., et al.. (1962). Synthesis of Some 8-Substituted Bis(β-chloroethyl)amino Derivatives of Naturally Occurring N-Methylated Purines1. The Journal of Organic Chemistry. 27(6). 2173–2177. 7 indexed citations
16.
Springer, Robert H., et al.. (1962). Communication to the Editor: Synthesis of Bacimethrin. The Journal of Organic Chemistry. 27(4). 1492–1492. 2 indexed citations
17.
Springer, Robert H., et al.. (1962). Pyrimidines. V. Analogs of 2-(o-Chlorobenzylthio)-4-dimethylamino- 5-methylpyrimidine (Bayer DG-428)1. The Journal of Organic Chemistry. 27(1). 181–185. 11 indexed citations
18.
Springer, Robert H., et al.. (1961). Pyrimidines. I. Synthesis of Pyrimidinethiols1,2. The Journal of Organic Chemistry. 26(3). 792–803. 35 indexed citations
19.
Springer, Robert H., et al.. (1961). Pyrimidines. IV. Aziridinylpyrimidines1. The Journal of Organic Chemistry. 26(6). 1884–1890. 4 indexed citations
20.
Springer, Robert H.. (1960). ZUM WIRKUNGSMECHANISMUS DES FLUORACETATS IM SÄURESTOFFWECHSEL VONASPERGILLUS NIGER1. Planta Medica. 8(4). 411–419. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026